National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J01DE01	CEFIPEX 1000 BENTA	G	Cefepime - 1,000mg	1,000mg	Injectable dry powder+diluent	703,918 L.L
R05X	COLD-MED	G	Glyceryl guaiacolate - 15mg/5ml, Pseudoephedrine HCl - 15mg/5ml, Pyrilamine maleate - 6.25mg/5ml, Paracetamol - 120mg/5ml		Syrup	386,515 L.L
J01DE01	CEFIPEX 1000 BENTA	G	Cefepime (hydrochloride) - 1,000mg	1,000mg	Injectable solution	703,918 L.L
R05X	CODOPALM EXPECTORANT	G	Ipeca Tincture - 3mg, Promethazine HCl - 100mg, Potassium guaiacosulfonate - 0.9g		Syrup	153,582 L.L
R05X	CODOPALM EXPECTORANT	G	Ipeca Tincture - 3mg, Promethazine HCl - 100mg, Potassium guaiacosulfonate - 0.9g		Syrup	291,806 L.L
L01XX05	CUREAML	G	Hydroxycarbamide (or Hydroxyurea) - 500mg	500mg	Capsule	1,228,272 L.L
L01XX05	CYTODROX	G	Hydroxycarbamide (or Hydroxyurea) - 500mg	500mg	Capsule	3,301,821 L.L
P01BA02	CORVAQUINE	G	Hydroxychloroquine sulfate - 200mg	200mg	Tablet, film coated	1,087,873 L.L
V03AF03	CALCIUMFOLINAT EBEWE	G	Calcium folinate - 100mg/10ml	100mg/10ml	Injectable solution	1,289,872 L.L
M01AB05	CLOREN ADULTS	G	Diclofenac sodium - 100mg	100mg	Suppository	598,970 L.L
R05X	COLDIN-H	G	Paracetamol - 300mg, Mepyramine maleate - 15mg, Noscapine - 10mg		Capsule	386,515 L.L
M01AB05	CLOFEN	G	Diclofenac sodium - 75mg/3ml	75mg/3ml	Injectable solution	299,677 L.L
B05XA07	CALCIUM CHLORIDE	G	Calcium chloride - 10g/100ml	10g/100ml	Injectable solution	5,436,771 L.L
M01AB05	CLOREN	G	Diclofenac sodium - 12.5mg	12.5mg	Suppository	353,239 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE C	G	Potassium chloride - 2.611g/l, Magnesium chloride, 6H2O - 5.33g/l, Calcium chloride, 2H2O - 8.99g/l, Sodium acetate, 3H2O - 190.505g/l, Sodium chloride - 204.54g/l		Injectable solution	L.L
C09DB07	CANDAM	G	Candesartan cilexetil - 8mg, Amlodipine - 5mg		Capsule, hard	1,376,095 L.L
L01EA01	CEMIVIL	G	Imatinib - 400mg	400mg	Tablet, film coated	41,106,321 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE D	G	Potassium chloride - 5.215g/l, Magnesium chloride, 6H2O - 5.32g/l, Calcium chloride, 2H2O - 8.99g/l, Sodium acetate, 3H2O - 166.7g/l, Sodium chloride - 214.76g/l		Injectable solution	L.L
C09DB07	CORONOPINE	G	Candesartan cilexetil - 8mg, Amlodipine - 5mg		Capsule, hard	1,368,032 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE E	G	Potassium chloride - 2.611g/l, Magnesium chloride, 6H2O - 5.32g/l, Calcium chloride, 2H2O - 7.00g/l, Sodium acetate, 3H2O - 190.505g/l, Sodium chloride - 205.49g/l		Injectable solution	L.L
C09DB07	CANDAM	G	Candesartan cilexetil - 16mg, Amlodipine - 5mg		Capsule, hard	1,376,095 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE F	G	Potassium chloride - 3.914g/l, Magnesium chloride, 6H2O - 3.558g/l, Calcium chloride, 2H2O - 7.719g/l, Acetic acid 100% - 6.010ml/l, Sodium chloride - 208.631g/l		Injectable solution	L.L
C09DB07	CORONOPINE	G	Candesartan cilexetil - 16mg, Amlodipine - 5mg		Capsule, hard	1,638,144 L.L
J01DH51	CELLABAXIN	G	Imipenem (monohydrate) - 500mg, Cilastatin (sodium) - 500mg		Injectable solution	10,699,559 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE SG	G	Potassium chloride - 3.92g/l, Magnesium chloride, 6H2O - 5.32g/l, Calcium chloride, 2H2O - 8.99g/l, Sodium acetate, 3H2O - 166.7g/l, Sodium chloride - 214.76g/l		Injectable solution	L.L
C09DB07	CANDAM	G	Candesartan cilexetil - 16mg, Amlodipine - 10mg		Capsule, hard	1,376,095 L.L
G03DA04	CYCLOGEST	G	Progesterone - 400mg	400mg	Pessary	1,546,763 L.L
J01DH51	CILANEM	G	Imipenem anhydrous - 500mg, Cilastatin (sodium) - 500mg		Injectable solution	850,652 L.L
R06AD52	CODOPALM	G	Promethazine HCl - 5mg/5ml, Sodium gentisate - 0.5mg/5ml		Syrup	149,742 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS L	G	Potassium chloride - K+:1.5 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.75 mmol/l, Sodium acetate - Cl-:106.5 mmol/l, Sodium chloride - Na+:135 mmol/l		Injectable solution	L.L

National Cancer Registry (NCR)